Wordt geladen...
EGFR methylation and outcome of patients with advanced colorectal cancer treated with cetuximab
Targeted therapy of metastatic colorectal cancer (mCRC) with monoclonal antibody anti-epidermal growth factor receptor (EGFR) agents, such as cetuximab (CTX) or panitumumab, is the treatment strategy of choice in patients characterised by a wild-type (wt) RAS gene status. However, despite selection...
Bewaard in:
| Gepubliceerd in: | Oncol Lett |
|---|---|
| Hoofdauteurs: | , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
D.A. Spandidos
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4315084/ https://ncbi.nlm.nih.gov/pubmed/25663927 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2015.2876 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|